CFM
OMGA

Catalyst Funds Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Catalyst Funds Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,100
Closed -$7.44K – 1343
2024
Q3 		$7.44K Hold
6,100
– – ﹤0.01% 1218
2024
Q2 		$12.6K Buy
+6,100
New +$14.4K ﹤0.01% 843

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Catalyst Funds Management's OMGA Position: Q4 2024 in Review

Catalyst Funds Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2024, closing a stake of 6,100 shares — an estimated $7.44K sold.

Catalyst Funds Management first reported a position in OMGA in Q2 2024 and held it in 2 quarters. The position peaked at $12.6K in Q2 2024. 53 funds tracked by Wall St. Rank hold OMGA as of Q4 2024.

  • Catalyst Funds Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 6,100 Omega Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $7.44K.
  • Catalyst Funds Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Omega Therapeutics, Inc. Common Stock position peaked at $12.6K in Q2 2024.
  • 53 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.